pi3k inhibitors for relapsed/refractory fl
Published 4 years ago • 38 plays • Length 3:40Download video MP4
Download video MP3
Similar videos
-
2:02
pi3k inhibition for r/r follicular lymphoma
-
3:13
choosing a pi3k inhibitor in relapsed follicular lymphoma
-
2:52
idelalisib for relapsed/refractory fl
-
5:33
managing toxicities of pi3k inhibitors in fl
-
20:01
emerging practice strategies for pi3k inhibitors in relapsed/refractory follicular lymphoma
-
4:22
adverse events associated with pi3k inhibitors in fl
-
4:27
treating r/r follicular lymphoma with pi3k inhibitors
-
8:32
pi3k-targeted therapy for r/r follicular lymphoma
-
3:37
pi3-kinase inhibitors for follicular lymphoma
-
4:29
pi3 kinase inhibitors as third-line therapy in fl
-
1:40
options for treating relapsed/refractory follicular lymphoma
-
3:47
pi3k inhibitors in management of r/r follicular lymphoma
-
2:31
copanlisib as a treatment for patients with relapsed/refractory indolent b-cell lymphoma
-
30:25
exploring novel approaches with pi3k inhibitors in r/r follicular and marginal zone lymphoma
-
2:44
pi3k inhibitors in r/r dlbcl
-
1:28:40
a better blend for fl: targeted, epigenetic, and immune therapies
-
21:19
other new molecules in the cll pipeline: pi3k inhibitors, syk inhibitors, etc.
-
22:46
follicular lymphoma debate: chemotherapy no longer has a major role in the treatment
-
22:33
epigenetic therapy for lymphoma: from the laboratory to the clinic